Yes people,some are gloating at the demise of the sp...and why shouldn't you...however it will be short lived...today's announcement was about $70 mill short,but you people just don't understand Biotechs.Now I think we have a Swedish PHARMA as our top holder in the register.When TEVA partnered Atl 1102 for MS they also stipulated all related diseases were theirs..Atl1103 is only for Acromegaly and all the other diseases for Atl 1103 belong to Anp...Anp are free carried with milestones and royalties which are confidential...we can now concentrate on MS and prostate cancer ...we have or will have $7 mill in the bank....revenue from Ms in Europe..to be announced soon...watch this space...we are better off than yesterday...I'm still Excited....
Great starter deal for ANP.
-
- There are more pages in this discussion • 103 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
